Development Of Prostate Cancer Bone Metastasis Delayed By Denosumab

Links shared publicly online about this topic.

0
total visits

Development Of Prostate Cancer Bone Metastasis Delayed By Denosumab

An international clinical trial has found that treatment with a drug that suppresses the normal breakdown of bone can delay the development of bone metastases in men with prostate cancer. The stud

View full resource at medicalnewstoday.com

Tags: Cancer, Bone Cancer, Bone Metastasis, Prostate Cancer, Bone, Osteoporosis Medication, Prostate, Men's Health

Most Recently Shared on November 16, 2011 at 10:07 am By:

MNT Prostate News

Development Of Prostate Cancer Bone Metastasis Delayed By Denosumab http://t.co/1LkhIR3M #prostate

5 months ago...

Retweet

Favorite

Also Shared By:

MNT Bones/Orthopedic

Denosumab Lowers Bone Metastasis Risk in CRPC Patients - Renal and Urology News

renalandurologynews.com — “MONTREAL—Denosumab significantly prolongs bone metastasis-free survival (BMFS) and delays time to bone metastasis in men with castration-resistant prostate cancer (CRPC), according to data presented at the Canadian Urological Association annual meeting.” View full resource at renalandurologynews.com